---
category: news
title: "Metis Therapeutics emerges with $86M for 2022 clinic entry, push into gene therapy"
excerpt: "Metis Therapeutics launched with $86 million to test its lead candidate in an early-2022 clinical trial and to bankroll the in-licensing of new assets. The small-molecule and RNA therapeutics biotech will also expand into CRISPR and gene therapy delivery in the coming year."
publishedDateTime: 2021-12-07T10:00:00Z
originalUrl: "https://www.fiercebiotech.com/biotech/metis-therapeutics-emerges-86m-for-2022-clinic-entry-push-into-gene-therapy"
webUrl: "https://www.fiercebiotech.com/biotech/metis-therapeutics-emerges-86m-for-2022-clinic-entry-push-into-gene-therapy"
type: article
quality: 33
heat: 33
published: false

provider:
  name: FierceBiotech
  domain: fiercebiotech.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://qtxasset.com/fiercebiotech/1638825497/Chris.jpg?VersionId=ebQfvaTvVaX7Xl_bUYgXrxTN9opHCYN_"
    width: 2048
    height: 2048
    isCached: true

secured: "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;wcfKig+3qsLh5UkxniqI1Q=="
---

